Fruquintinib in patients with metastatic colorectal cancer failed in previously bevacizumab-based therapy: A monocentric retrospective study.

被引：0
|
作者：
Gu, Xiaoqiang [1 ]
机构：
[1] Shanghai Univ Tradit Chinese Med, LongHua Hosp, Oncol, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.e15555
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15555
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Bevacizumab in patients with previously treated metastatic colorectal cancer: preliminary results of a phase II study (bevacolor)
    Borg, C.
    Delord, J. P.
    Husseini, F.
    Lenoir, V. Trillet
    Faroux, R.
    Francois, E.
    Ychou, M.
    Bergougnoux, L.
    Bennouna, J.
    Douillard, J. Y.
    EJC SUPPLEMENTS, 2007, 5 (04): : 257 - 257
  • [42] Whole-brain radiation therapy in breast cancer patients with brain metastasis previously treated with bevacizumab-based chemotherapy
    Chira, C.
    Jacob, J.
    Bollet, M.
    Derhem, N.
    Campana, F.
    Dendale, R.
    Marchand, V.
    Pierga, J.
    Fourquet, A.
    Kirova, Y.
    JOURNAL OF NEUROLOGY, 2011, 258 : 109 - 109
  • [43] Bevacizumab-Based Chemotherapy Combined with Regional Deep Capacitive Hyperthermia in Metastatic Cancer Patients: A Pilot Study
    Ranieri, Girolamo
    Ferrari, Cristina
    Di Palo, Alessandra
    Marech, Ilaria
    Porcelli, Mariangela
    Falagario, Gianmarco
    Ritrovato, Fabiana
    Ramunni, Luigi
    Fanelli, Margherita
    Rubini, Giuseppe
    Gadaleta, Cosmo Damiano
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (07)
  • [44] Long-term responders to first-line bevacizumab-based therapy among patients (pts) with HER2-negative metastatic breast cancer (MBC): Retrospective results of an ambispective observational study.
    Ramos Vazquez, Manuel
    Redondo, Andres
    Ghanem, Ismael
    Gil Gil, Miguel J.
    Garau Llinas, Isabel
    Perez-Carrion, Ramon
    Garcia-Garre, Elisa
    Augusto Rodriguez, Cesar
    Ignacio Chacon, Jose
    Lopez-Vivanco, Guillermo
    Perello, Antonia
    Espinosa Aunion, Ruth
    Morales, Serafin
    Ortega, Vanessa
    Garcia Saenz, Jose Angel
    Martinez, Noelia
    Gonzalez, Paula
    Arcusa Lanza, Angels
    Jose Echarri, Maria
    Medina, Ana
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] Modified FOLFOXIRI regimen as salvage treatment for metastatic colorectal cancer patients: A retrospective study.
    Wang, Zhen
    Zheng, Song
    Xu, Xifeng
    Qian, Yuan
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [46] Effect of prognostic nutritional index on laboratory parameters and survival in metastatic colorectal cancer patients treated with fruquintinib: a retrospective study
    Wang, Zeng
    Zhao, Sining
    Zhang, Xuan
    Mao, Xinyi
    Yang, Guonong
    Yuan, Meiqin
    Zhou, Xiaofang
    PEERJ, 2024, 12
  • [47] Overall survival with fruquintinib versus placebo after adjusting for subsequent anticancer therapy in patients with refractory metastatic colorectal cancer in the FRESCO-2 study.
    Dasari, Arvind
    Tabernero, Josep
    Garcia-Carbonero, Rocio
    Elez, Elena
    Yoshino, Takayuki
    Sobrero, Alberto F.
    Yao, James C.
    Garcia-Alfonso, Pilar
    Kocsis, Judit
    Cubillo Gracian, Antonio
    Sartore-Bianchi, Andrea
    Satoh, Taroh
    Randrian, Violaine
    Tomasek, Jiri
    Chong, Geoff
    Paulson, Andrew Scott
    Wu, Liwen
    Chen, Lucy F.
    Eng, Cathy
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 171 - 171
  • [48] Bevacizumab or standard chemotherapy in previously treated patients with metastatic colorectal cancer - a systematic review
    Kaczor, Marcin
    Staskiewicz, Wojciech
    Homa, Monika
    Gorecka, Magdalena
    Wojcik, Rafal
    Potemski, Piotr
    ONCOLOGY IN CLINICAL PRACTICE, 2021, 17 (01): : 14 - 27
  • [49] Necrosis in breast cancer patients with skin metastases receiving bevacizumab-based therapy
    Cottu, P. H.
    Fourchotte, V.
    Vincent-Salomon, A.
    Kriegel, I.
    Fromantin, I.
    JOURNAL OF WOUND CARE, 2011, 20 (09) : 403 - +
  • [50] Angiotensin II type-1 receptor blockers enhance the effects of bevacizumab-based chemotherapy in metastatic colorectal cancer patients
    Osumi, Hiroki
    Matsusaka, Satoshi
    Wakatsuki, Takeru
    Suenaga, Mitsukuni
    Shinozaki, Eiij
    Mizunuma, Nobuyuki
    MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (06) : 1295 - 1300
12345